PLC Systems to Host Fourth Quarter Conference Call on March 5, 2008
2008年2月27日 - 11:27PM
PRニュース・ワイアー (英語)
FRANKLIN, Mass., Feb. 27 /PRNewswire-FirstCall/ -- PLC Systems Inc.
(AMEX:PLC) announced today that it expects to release to the news
wire its financial results for the fourth quarter ended December
31, 2007 before the market opens on Wednesday, March 5, 2008. The
company plans to host a conference call to discuss those results at
11:00 a.m. ET on that same day. The call may be joined via
telephone by dialing (888) 713-4205 or (617) 213-4862 (for
international participants) at least five minutes prior to the
start of the call. The conference ID code is: 25917459. A live
webcast of the conference call will be available by visiting the
PLC Systems website, http://www.plcmed.com/ five minutes before the
call begins. The webcast will be archived on this site starting one
hour after the call is completed. In addition, a telephonic replay
of the call will be available beginning at 1:00 p.m. ET on March 5,
2008, through midnight on March 12, 2008, and can be accessed by
dialing (888) 286-8010 or (617) 801-6888 (for international
participants), using conference ID code 90665991. About PLC Systems
Inc. PLC Systems Inc. is a medical technology company specializing
in innovative technologies for the cardiac and vascular markets.
Headquartered in Franklin, Mass., PLC pioneered the CO2 Heart Laser
System, which cardiac surgeons use to perform CO2 transmyocardial
revascularization (TMR) to alleviate symptoms of severe angina. CO2
TMR offers a treatment option for angina patients who suffer from
severe coronary artery disease. The CO2 Heart Laser is the world's
first TMR angina relief device cleared for commercial distribution
by both the U.S. Food and Drug Administration and Japanese Ministry
of Health, Labor and Welfare, and to obtain a CE Mark for European
distribution. The company recently concluded a pilot clinical
safety study of its RenalGuard Therapy(TM) and RenalGuard
System(TM). In late 2007, the company received its CE Mark
Certificate for RenalGuard System. RenalGuard Therapy is designed
to reduce the toxic effects that contrast media can have on the
kidneys. This therapy is based on the theory that creating and
maintaining a high urine output is beneficial to patients
undergoing imaging procedures where contrast agents are used. The
real-time measurement and matched fluid replacement design of the
RenalGuard System is intended to ensure that a high urine flow is
maintained before, during and after these procedures. This should
allow the body to rapidly eliminate contrast, reducing its toxic
effects. The RenalGuard System, with its matched fluid replacement
capability, is intended to minimize the risk of over- or
under-hydration. Additional company information can be found at
http://www.plcmed.com/. PLC Systems, PLC Medical Systems, PLC, CO2
Heart Laser, RenalGuard, RenalGuard System and RenalGuard Therapy
are trademarks of PLC Systems Inc. Contact: Mary T. Conway Conway
Communications 617-244-9682 DATASOURCE: PLC Systems Inc. CONTACT:
Mary T. Conway of Conway Communications, +1-617-244-9682, , for PLC
Systems Inc. Web site: http://www.plcmed.com/
Copyright
P L C Systems (AMEX:PLC)
過去 株価チャート
から 11 2024 まで 12 2024
P L C Systems (AMEX:PLC)
過去 株価チャート
から 12 2023 まで 12 2024
Real-Time news about Plc Systems, (アメリカ証券取引所): 0 recent articles
その他のPlc Systems,ニュース記事